Dissecting the structural determinants of the interaction between the human cytomegalovirus UL18 protein and the CD85j immune receptor

Journal of Immunology

Volumn 180, Issue 2, 2008, Pages 957-968

  Occhino, Marzia ^a   Ghiotto, Fabio ^a   Soro, Simonetta ^b   Mortarino, Mimosa ^c   Bosi, Stefania ^b   Maffei, Massimo ^a   Bruno, Silvia ^a   Nardini, Marco ^d   Figini, Mariangela ^c   Tramontano, Anna ^b   Ciccone, Ermanno ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BETA 2 MICROGLOBULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN UL18; RECEPTOR; RECEPTOR CD85J; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; CAPSID PROTEIN; DNA BINDING PROTEIN; DRP90 PROTEIN, GLYCINE MAX; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; LILRB1 PROTEIN, HUMAN; VEGETABLE PROTEIN; VP23 PROTEIN, HUMAN HERPESVIRUS 1;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; EMBRYO; FEMALE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MOLECULAR MODEL; MOUSE; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; AMINO ACID SEQUENCE; CELL LINE; CHEMISTRY; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANTIGENS, CD; CAPSID PROTEINS; CELL LINE; CONSERVED SEQUENCE; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; PLANT PROTEINS; RECEPTORS, IMMUNOLOGIC;

EID: 40449096658     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.2.957     Document Type: Article

References (41)

1. Beck, S., and B. G. Barrell. 1988. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 331: 269-272.
2. Hassan-Walker, A. F., I. M. Kidd, C. Sabin, P. Sweny, P. D. Griffiths, and V. C. Emery. 1999. Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: relationship with donor/ recipient CMV serostatus, receipt of augmented methylprednisolone, and antithymocyte globulin (ATG). J. Med. Virol. 58: 182-187.
3. Browne, H., M. Churcher, and T. Minson. 1992. Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted. J. Virol. 66: 6784-6787.
4. Browne, H., G. Smith, S. Beck, and T. Minson. 1990. A complex between the MHC class I homologue encoded by human cytomegalovirus and β 2 microglobulin. Nature 347: 770-772.
5. Fahnestock, M. L., J. L. Johnson, R. M. Feldman, J. M. Neveu, W. S. Lane, and P. J. Bjorkman. 1995. The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 3: 583-590.
6. Griffin, C., E. C. Wang, B. P. McSharry, C. Rickards, H. Browne, G. W. Wilkinson, and P. Tomasec. 2005. Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18. J. Gen. Virol. 86: 2999-3008.
7. Cosman, D., N. Fanger, L. Borges, M. Kubin, W. Chin, L. Peterson, and M. L. Hsu. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7: 273-282.
8. Colonna, M., F. Navarro, T. Bellon, M. Llano, P. Garcia, J. Samaridis, L. Angman, M. Cella, and M. Lopez-Botet. 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186: 1809-1818.
9. Dietrich, J., M. Cella, and M. Colonna. 2001. Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization. J. Immunol. 166: 2514-2521.
10. Saverino, D., A. Merlo, S. Bruno, V. Pistoia, C. E. Grossi, and E. Ciccone. 2002. Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells. J. Immunol. 168: 207-215.
11. Chapman, T. L., A. P. Heikeman, and P. J. Bjorkman. 1999. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11: 603-613.
12. Chapman, T. L., A. P. Heikema, A. P. West, and P. J. Bjorkman. 2000. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). Immunity 13: 727-736.
13. Willcox, B. E., L. M. Thomas, and P. J. Bjorkman. 2003. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat. Immunol. 4: 913-919.
14. Cerboni, C., A. Achour, A. Warnmark, M. Mousavi-Jazi, T. Sandalova, M. L. Hsu, D. Cosman, K. Karre, and E. Carbone. 2006. Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j. Eur. J. Immunol. 36: 732-741.
15. Vales-Gomez, M., M. Shiroishi, K. Maenaka, and H. T. Reyburn. 2005. Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2. J. Virol. 79: 2251-2260.
16. Farrell, H. E., H. Vally, D. M. Lynch, P. Fleming, G. R. Shellam, A. A. Scalzo, and N. J. Davis-Poynter. 1997. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 386: 510-514.
17. Reyburn, H. T., O. Mandelboim, M. Vales-Gomez, D. M. Davis, L. Pazmany, and J. L. Strominger. 1997. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386: 514-517.
18. Leong, C. C., T. L. Chapman, P. J. Bjorkman, D. Formankova, E. S. Mocarski, J. H. Phillips, and L. L. Lanier. 1998. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J. Exp. Med. 187: 1681-1687.
19. + T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells. J. Immunol. 172: 5629-5637.
20. Wagner, C. S., G. C. Riise, T. Bergstrom, K. Karre, E. Carbone, and L. Berg. 2007. Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection. J. Immunol. 178: 3536-3543.
21. Greten, T. F., F. Korangy, G. Neumann, H. Wedemeyer, K. Schlote, A. Heller, S. Scheffer, D. M. Pardoll, A. I. Garbe, J. P. Schneck, and M. P. Manns. 2002. Peptide-β2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes. J. Immunol. Methods 271: 125-135.
22. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25: 3389-3402.
23. Soding, J., A. Biegert, and A. N. Lupas. 2005. The HHpred interactive server for protein homology detection and structure prediction. Nucleic Acids Res. 33: W244-W248.
24. Wallace, I. M., O. O'Sullivan, D. G. Higgins, and C. Notredame. 2006. M-coffee: combining multiple sequence alignment methods with T-coffee. Nucleic Acids Res. 34: 1692-1699.
25. Rost, B., G. Yachdav, and J. Liu. 2004. The PredictProtein server. Nucleic Acids Res. 32: W321-W326.
26. Kabsch, W., and C. Sander. 1983. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22: 2577-2637.
27. Sali, A., and T. L. Blundell. 1993. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234: 779-815.
28. Canutescu, A. A., A. A. Shelenkov, and R. L. Dunbrack. 2003. A graph-theory algorithm for rapid protein side-chain prediction. Protein Sci. 12: 2001-2014.
29. Gautier, R., A. C. Camproux, and P. Tuffery. 2001. SCit: web tools for protein side chain conformation analysis. Nucleic Acids Res. 32: W508-W511.
30. Ye, Y., and A. Godzik. 2003. Flexible structure alignment by chaining aligned fragment pairs allowing twists. Bioinformatics 19(Suppl. 2): ii246 -ii255.
31. Chothia, C., and A. M. Lesk. 1986. The relation between the divergence of sequence and structure in proteins. EMBO J. 5: 823-826.
32. Lesk, A. M., M. Levitt, and C. Chothia. 1986. Alignment of the amino acid sequences of distantly related proteins using variable gap penalties. Protein Eng. 1: 77-78.
33. Tramontano, A. 1998. Homology modeling with low sequence identity. Methods 14: 293-300.
34. Cozzetto, D., and A. Tramontano. 2005. Relationship between multiple sequence alignments and quality of protein comparative models. Proteins 58: 151-157.
35. Berman, H. M., S. K. Burley, W. Chiu, A. Sali, A. Adzhubei, P. E. Bourne, S. H. Bryant, R. L. Dunbrack, K. Fidelis, J. Frank, et al. 2006. Outcome of a workshop on archiving structural models of biological macromolecules. Structure 14: 1211-1217.
36. Gao, G. F., J. Tormo, U. C. Gerth, J. R. Wyer, A. J. McMichael, D. I. Stuart, J. I. Bell, E. Y. Jones, and B. K. Jakobsen. 1997. Crystal structure of the complex between human CD8α(α) and HLA-A2. Nature 387: 630-634.
37. Berman, H., K. Henrick, and H. Nakamura. 2003. Announcing the worldwide Protein Data Bank. Nat. Struct. Biol. 10: 980.
38. Crooks, G. E., G. Hon, J. M. Chandonia, and S. E. Brenner. 2004. WebLogo: a sequence logo generator. Genome Res. 14: 1188-1190.
39. Humphrey, W., A. Dalke, and K. Schulten. 1996. VMD: visual molecular dynamics. J. Mol. Graphics 14: 33-38.
40. Wagner, C. S., A. Rölle, D. Cosman, H. G. Ljunggren, K. D. Berndt, and A. Achour. 2007. Structural elements underlying the high binding affinity of human cytomegalovirus UL18 to leukocyte immunoglobulin-like receptor-1. J. Mol. Biol. 373: 695-705.
41. Maffei, M., F. Ghiotto, M. Occhino, M. Bono, A. De Santanna, L. Battini, G. L. Gusella, F. Fais, S. Bruno, and E. Ciccone. 2008. Human cytomegalovirus regulates surface expression of the viral protein UL18 by means of two motifs present in the cytoplasmic tail. J. Immunol. 180: 969-979.